OTHER
81MO Osimertinib as neoadjuvant therapy in patients with EGFR mutated resectable stage II-IIIB lung adenocarcinoma (NEOS): Updated results
Chuhl Joo Lyu, Wentao Fang, Weiqi Jiao, Haitao Ma, J. Wang, S. Xu, Nan Wu, R. Wang, Yongbo Yang
- Year
- 2022
- Citations
- 10
Keywords
MedicineOsimertinibNeoadjuvant therapyClinical endpointAdenocarcinomaAdverse effectInternal medicineLung cancerPopulationSurgery
Related papers
OTHER
📊 26,957 cites
Statistical Learning Theory
Yuhai Wu, Vladimir Vapnik
1999
OTHER
Open access📊 20,501 cites
Fractional Differential Equations
Igor Podlubný
2025
OTHER
📊 18,993 cites
Applied Nonlinear Control
Jean-Jacques Slotine, Weiping Li
1991
OTHER
📊 13,277 cites
Genetic Programming: On the Programming of Computers by Means of Natural Selection
John R. Koza
1992